Is Lifevantage Corp Safe? FDA Warning Letter Review (2017)
Compiled by the Supplement Safety Data Team | Sourced from Official FDA Records on April 17, 2017
Executive Summary
The FDA issued a warning letter to Lifevantage Corp on April 17, 2017 citing regulatory violations. Consumers who have purchased products from this company should exercise caution. The letter was issued by Denver District Office.
Detailed Analysis
False Claims and Regulatory Violations
“Cardiovascular diseases prevention”
“Diabetes prevention”
“Alzheimers [sic] prevention”
Potential Health Risks
“Minimizes risk of skin cancers”
“associated with lower lung cancer risk”
“reduce the risks of developing cancers such as breast, stomach, prostate, pancreatic and colorectal cancer.”
Regulatory Context
“Nrf2-activating phytonutrients such as EGCG from green tea, curcumin from turmeric, and quercetin from onions are known to reduce amyloid plaque accumulation (Alzheimer’s) and increase regeneration of dopamine fibers (Parkinson’s), suggesting a general neuro-protective benefit.”
Key Entities Identified
Frequently Asked Questions
- What did the FDA find wrong with Lifevantage Corp?
- The FDA issued a warning letter citing regulatory violations related to their products or manufacturing practices.
- Are Lifevantage Corp products safe to use?
- Based on the FDA's findings, consumers should exercise caution. The company was found to have regulatory issues that may affect product safety.
- What should I do if I've used Lifevantage Corp products?
- If you have used products from Lifevantage Corp and experience any adverse effects, contact your healthcare provider immediately. You can also report adverse events to the FDA's MedWatch program.
Source Document
This report is based on an official FDA warning letter. The original document is a public record.
View Original FDA Warning Letter